The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Bevacizumab in combination with TMZ in patients with recurrent GBM: Final OS and PFS analysis.
Juan Manuel Sepulveda
No relevant relationships to disclose
Cristobal Belda-Iniesta
No relevant relationships to disclose
Miquel Gil
No relevant relationships to disclose
Pedro Pérez Segura
No relevant relationships to disclose
Alfonso Berrocal
No relevant relationships to disclose
Gaspar Reynes
No relevant relationships to disclose
Oscar Gallego
No relevant relationships to disclose
Jose Manuel Ordonez
Employment or Leadership Position - Roche
Beatriz La Orden
Employment or Leadership Position - Roche
Carmen Balana
No relevant relationships to disclose